Asthma is increasingly recognised as a heterogeneous disease, with several phenotypes defined by clinical and inflammatory characteristics. Common phenotypes include allergic (eosinophilic, IgE-mediated), non-allergic (often neutrophilic or paucigranulocytic), late-onset adult asthma, obesity-associated asthma, and asthma with persistent airflow limitation.14 Identifying phenotypes supports individualised treatment strategies, particularly in those with severe asthma, and better long-term outcomes.
Steps 2 and 3: Maintenance and reliever therapy (MART)
Comorbid conditions can complicate asthma management. Assess for and help address factors such as allergic rhinitis, which affects up to 80% of people with asthma,24 as well as gastro-oesophageal reflux disease (GORD), anxiety, depression, obstructive sleep apnoea and smoking.
6CPA program audits coming
Programs funded under the Sixth Community Pharmacy Agreement (6CPA) will be subject to audits from next week to detect any inaccurate or ineligible claims.
The...
Why we need pharmacists integrated in Aboriginal Health Services
In 2001, after 20 years as a pharmacist in Sydney, I moved to Bathurst, a regional centre in NSW’s Central West. At the pharmacy,...
PSA’s national guidelines on MHR
It's been described as a 'game changer' for pharmacists and now there's a practical guide to unlocking the potential of My Health Record.
PSA's new...
Aged care in focus
The Royal Commission into Aged Care Quality and Safety has heard clear calls for pharmacists, as a priority, to spend more time on the...
Gallery: PSA18 social events
Hundreds of Australia's Early Career Pharmacists overtook Cafe Del Mar at Sydney's Cockle Bay Wharf on Friday evening for the lively annual PSA18 ECP...
How to get published
Conducting research can be a daunting prospect. But by choosing a mentor and working intelligently, pharmacists can research and have their work published.
A study...
